Developments in Oligometastatic Cancer
Barbara Alicja Jereczek-Fossa M.D., Ph.D. is an Associate Professor of Radiation Oncology at the University of Milan, Italy, Head of the Department of Radiation Oncology at the European Institute of Oncology in Milan, Director of the School of Specialization in Radiation Oncology and Chair of the BSc Degree for Radiographers of the University of Milan.
SBRT as a Salvage Option for Localized Recurrent Prostate Cancer
Donald B. Fuller, M.D. has been practicing medicine since 1988. He enjoys maximizing the power of technology against cancer by staying at the leading edge of technology innovation, and believes in putting new treatments into practice as soon as they become available.
Re-irradiation with SBRT for Pancreatic Cancer
Professor and Chairman of Radiation Oncology Department, Chairman of CyberKnife Center, Changhai Hospital, China
Prof. Zhang specializes in malignant tumor (pancreatic tumor, primary liver cancer, liver metastasis, lung cancer, renal cancer, prostate cancer as well as colon/rectum cancer) treatment with CyberKnife, SBRT and interventional radiology.
Planning for Multiple Brain Metastases with the CyberKnife® System
Dr. Daniela Schmitt is a medical physicist in the Department of Radiation Oncology at the Heidelberg University Hospital in Germany. Since the commencement of the CyberKnife Program at Heidelberg in 2016 Dr. Schmitt’s focus has been on CyberKnife planning. Prior to joining Heidelberg University Hospital in 2014 Dr. Schmitt worked at the CyberKnife Center in Frankfurt. She obtained her PhD in physics from the University of Heidelberg working at the German Cancer Research Center under the supervision of Prof. Uwe Oelfke in 2014.
Image-Guided Robotic Radiosurgery for Trigeminal Neuralgia
Frameless, non-isocentric irradiation of an extended segment of the trigeminal nerve introduces new concepts in stereotactic radiosurgery for medically resistant trigeminal neuralgia (TN).
Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
To asses the potential dosimetric benefits associated with the CyberKnife (CK) tumor tracking capability, wherein an extra margin for respiratory tumor motion is not required, when compared to respiratory-gated volumetric-modulated arc therapy (VMAT) for hepatocellular carcinoma (HCC).
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to the prostate while minimizing radiation to the adjacent critical organs. Large fraction sizes may increase urinary morbidity due to unavoidable treatment of the prostatic urethra. This study reports rates of acute urinary morbidity following SBRT for localized prostate cancer with prophylactic alpha-adrenergic antagonist utilization and urethral dose reduction (UDR).
Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife®
The efficacy of accelerated partial breast irradiation (APBI) utilizing brachytherapy or conventional external beam radiation has been studied in early-stage breast cancer treated with breast-conserving surgery. Data regarding stereotactic treatment approaches are emerging. The CyberKnife linear accelerator enables excellent dose conformality to target structures while adjusting for target and patient motion. We report our institutional experience on the technical feasibility and rationale for stereotactic accelerated partial breast irradiation (SAPBI) delivery using the CyberKnife radiosurgery system.
